Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012

Biochemical Pharmacology

Volumn 68, Issue 12, 2004, Pages 2435-2441

  Zhou, Jun ^a   Liu, Min ^a   Aneja, Ritu ^a   Chandra, Ramesh ^b   Joshi, Harish C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Apoptosis; Cancer; EM012; Microtubule; Mitosis; Paclitaxel

Indexed keywords

ALKALOID; PACLITAXEL;

ACETYLATION; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONCENTRATION (PARAMETERS); HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOFURANS; BREAST NEOPLASMS; DRUG SYNERGISM; FEMALE; HUMANS; ISOQUINOLINES; MALE; MICROTUBULES; MITOSIS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 8844273265     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.08.032     Document Type: Article

References (34)

1. P.M. Checchi, J.H. Nettles, J. Zhou, J.P. Snyder, and H.C. Joshi Microtubule-interacting drugs for cancer treatment Trends Pharmacol Sci 24 2003 361 365
2. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat Rev Cancer 4 2004 253 265
3. D. Panda, H.P. Miller, K. Islam, and L. Wilson Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action Proc Natl Acad Sci USA 94 1997 10560 10564
4. A.D. Seidman, H.I. Scher, D. Petrylak, D.D. Dershaw, and T. Curley Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer J Urol 147 1992 931 934
5. G.R. Hudes, F.E. Nathan, C. Khater, R. Greenberg, L. Gomella, and C. Stern Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer Semin Oncol 22 1995 41 45
6. G.R. Hudes, F. Nathan, C. Khater, N. Haas, M. Cornfield, and B. Giantonio Phase II trial of 96-h paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer J Clin Oncol 15 1997 3156 3163
7. G.R. Hudes, R. Greenberg, R.L. Krigel, S. Fox, R. Scher, and S. Litwin Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer J Clin Oncol 10 1992 1754 1761
8. V.C. Knick, D.J. Eberwein, and C.G. Miller Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells J Natl Cancer Inst 87 1995 1072 1077
9. A. Photiou, P. Shah, L.K. Leong, J. Moss, and S. Retsas In vitro synergy of paclitaxel (taxol) and vinorelbine (navelbine) against human melanoma cell lines Eur J Cancer 33 1997 463 470
10. H.A. Burris III, S. Fields, and N. Peacock Docetaxel (taxotere) in combination: a step forward Semin Oncol 22 1995 35 40
11. V. Dieras, P. Fumoleau, S. Kalla, J.L. Misset, N. Azli, and P. Pouillart Docetaxel in combination with doxorubicin or vinorelbine Eur J Cancer 33 Suppl 7 1997 S20 S22
12. K. Ye, Y. Ke, N. Keshava, J. Shanks, J.A. Kapp, and R.R. Tekmal Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells Proc Natl Acad Sci USA 95 1998 1601 1606
13. J. Zhou, K. Gupta, S. Aggarwal, R. Aneja, R. Chandra, and D. Panda Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation Mol Pharmacol 63 2003 799 807
14. J. Zhou, D. Panda, J.W. Landen, L. Wilson, and H.C. Joshi Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint J Biol Chem 277 2002 17200 17208
15. J.W. Landen, R. Lang, S.J. McMahon, N.M. Rusan, A.M. Yvon, and A.W. Adams Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma Cancer Res 62 2002 4109 4114
16. K. Ye, J. Zhou, J.W. Landen, E.M. Bradbury, and H.C. Joshi Sustained activation of p34 (cdc2) is required for noscapine-induced apoptosis J Biol Chem 276 2001 46697 46700
17. J. Zhou, K. Gupta, J. Yao, K. Ye, D. Panda, and P. Giannakakou Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine J Biol Chem 277 2002 39777 39785
18. Y. Ke, K. Ye, H.E. Grossniklaus, D.R. Archer, H.C. Joshi, and J.A. Kapp Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses Cancer Immunol Immunother 49 2000 217 225
19. Zhou J, Liu M, Luthra R, Jones J, Aneja R, Chandra R, et al. EM012, a microtubule-interfering agent, inhibits the progression of multidrug-resistant human ovarian cancer both in cultured cells and in athymic nude mice. Cancer Chemother Pharmacol (in press).
20. E. Hamel, and C.M. Lin Glutamate-induced polymerization of tubulin: characteristics of the reaction and application to the large-scale purification of tubulin Arch Biochem Biophys 209 1981 29 40
21. H.C. Joshi, and J. Zhou Gamma tubulin and microtubule nucleation in mammalian cells Methods Cell Biol 67 2001 179 193
22. F. Mollinedo, and C. Gajate Microtubules, microtubule-interfering agents and apoptosis Apoptosis 8 2003 413 450
23. V.M. Heatwole TUNEL assay for apoptotic cells Methods Mol Biol 115 1999 141 148
24. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1980 1561 1565
25. M.A. Jordan, R.J. Toso, D. Thrower, and L. Wilson Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations Proc Natl Acad Sci USA 90 1993 9552 9556
26. W.B. Derry, L. Wilson, and M.A. Jordan Substoichiometric binding of taxol suppresses microtubule dynamics Biochemistry 34 1995 2203 2211
27. M.A. Jordan, K. Wendell, S. Gardiner, W.B. Derry, H. Copp, and L. Wilson Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death Cancer Res 56 1996 816 825
28. A.M. Yvon, P. Wadsworth, and M.A. Jordan Taxol suppresses dynamics of individual microtubules in living human tumor cells Mol Biol Cell 10 1999 947 959
29. E. Hamel Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin Cell Biochem Biophys 38 2003 1 22
30. G. Piperno, M. LeDizet, and X.J. Chang Microtubules containing acetylated alpha-tubulin in mammalian cells in culture J Cell Biol 104 1987 289 302
31. J. Rosenbaum Cytoskeleton: functions for tubulin modifications at last Curr Biol 10 2000 801 803
32. S. Westermann, and K. Weber Post-translational modifications regulate microtubule function Nat Rev Mol Cell Biol 4 2003 938 947
33. E.K. Rowinsky The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 48 1997 353 374
34. H. Madari, D. Panda, L. Wilson, and R.S. Jacobs Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with taxol Cancer Res 63 2003 1214 1220